Synapse - Guenther Koehne

Results (144)

Re-immunization following autologous hematopoietic stem cell transplantation (Auto HCT) is safe and effective in patients with multiple myeloma receiving lenalidomide maintenance

Meeting Abstract

Shah, G.; Palazzo, M.; Copelan, O.; Seier, K.; Devlin, S.; Hassoun, H.; Korde, N.; Lendvai, N.; Lesokhin, A.; Mailankody, S.; more...
Clinical Lymphoma, Myeloma and Leukemia (2017)

Fulltext@MSK | Save

Improvement of response for multiple myeloma patients on lenalidomide maintenance after autologous hematopoietic stem cell transplantation (Auto HCT)

Meeting Abstract

Shah, G.; Assal, A.; Hsu, M.; Devlin, S.; Hassoun, H.; Korde, N.; Lendvai, N.; Lesokhin, A.; Mailankody, S.; Smith, E.; more...
Clinical Lymphoma, Myeloma and Leukemia (2017)

Fulltext@MSK | Save

Proteomic profiling in plasma cell disorders: A feasibility study

Journal Article

Mailankody, S.; Devlin, S. M.; Korde, N.; Lendvai, N.; Lesokhin, A.; Landau, H.; Hassoun, H.; Ballagi, A.; Ekman, D.; Chung, D. J.; more...
Leukemia and Lymphoma (2017)

Fulltext@MSK | Save

Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation

Journal Article

Shah, G. L.; Landau, H.; Londono, D.; Devlin, S. M.; Kosuri, S.; Lesokhin, A. M.; Lendvai, N.; Hassoun, H.; Chung, D. J.; Koehne, G.; more...
Leukemia and Lymphoma (2017)

Fulltext@MSK | Save

Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: Efficacy and analysis of risk factors associated with poor stem cell collection efficiency*

Journal Article

Ogunniyi, A.; Rodriguez, M.; Devlin, S.; Adel, N.; Landau, H.; Chung, D. J.; Lendvai, N.; Lesokhin, A.; Koehne, G.; Mailankody, S.; more...
Leukemia and Lymphoma (2017)

Fulltext@MSK | Save

Ex vivo CD34(+)–selected T cell–depleted peripheral blood stem cell grafts for allogeneic hematopoietic stem cell transplantation in acute leukemia and myelodysplastic syndrome is associated with low incidence of acute and chronic graft-versus-host disease and high treatment response

Journal Article

Barba, P.; Hilden, P.; Devlin, S. M.; Maloy, M.; Dierov, D.; Nieves, J.; Garrett, M. D.; Sogani, J.; Cho, C.; Barker, J. N.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Hematopoietic cell transplantation comorbidity index predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving CD34(+) selected grafts for allogeneic hematopoietic cell transplantation

Journal Article

Barba, P.; Ratan, R.; Cho, C.; Ceberio, I.; Hilden, P.; Devlin, S. M.; Maloy, M. A.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Comparable survival and incidence of toxicity for older adult patients after CD34+ selected allogeneic hematopoietic stem cell transplantation

Meeting Abstract

Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Maloy, M. A.; Nieves, J.; Devlin, S.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
Blood (2016)

Fulltext@MSK | Save

Third party CMV-specific cytotoxic T cells for treatment of antiviral resistant CMV infection after hematopoietic stem cell transplant

Meeting Abstract

Prockop, S.; Doubrovina, E.; Hasan, A. N.; Dahi, P. B.; Giralt, S.; Koehne, G.; Kernan, N. A.; Papadopoulos, E. B.; Lehrman, R.; Rodriguez-Sanchez, I.; more...
Blood (2016)

Fulltext@MSK | Save

A comprehensive analysis of late toxicities and associated risk factors in long-term survivors of myeloablative conditioned allogeneic hematopoietic cell transplantation using ex-vivo CD34+ selection-based graft-versus-host disease prophylaxis

Meeting Abstract

Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Devlin, S.; Maloy, M. A.; Nieves, J.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
Blood (2016)

Fulltext@MSK | Save